.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Greenline’s mix tilted toward inhalables, with Flower at 38.66% share and Concentrates at 30.90%, while Vapor Pens and Pre-Roll held 17.19% and 13.22% respectively; Topical was negligible at 0.04%. Year over year, Pre-Roll surged 160.27% and Concentrates rose 77.13%, outpacing Flower at 56.08% and Vapor Pens at 47.24%; Topical contracted 64.13%. Month over month, growth concentrated in Flower at 8.84% and Concentrates at 10.83%, contrasted with declines in Vapor Pens at 3.06% and Pre-Roll at 2.85%, while Topical fell 69.44%. The pattern implies Greenline is concentrating assortment and promo energy into Flower and Concentrates to drive mix-led expansion while pruning low-velocity Topical and easing Vapor Pens exposure.
With brand sales up 69.29% year over year alongside a 2.39% average price decrease, unit-led gains are likely coming from Flower’s higher ticket at $26.75 and Concentrates’ volume at an $11.42 price point, while Vapor Pens at $14.70 and Pre-Roll at $8.26 serve as price-access channels. The mix skews toward California Flower where Greenline sits around rank 50, so the 8.84% month-over-month Flower lift and 10.83% Concentrates lift suggest targeted execution in a mid-pack position rather than broad pricing pressure, especially as Vapor Pens slipped 3.06% and Pre-Roll slipped 2.85%. The implication is a push to gain share through depth in two lead categories and defend margin with controlled pricing, accepting Vapor Pens and Pre-Roll softness as the trade-off for higher-velocity, higher-rank headway in core inhalables.
Competitive Landscape
Greenline sits at rank #50 in CA Flower in May 2026, improving 34 positions year over year from #84, while slipping 1 spot from #51 in February 2026 and coming off a peak of #49 in March 2026; by comparison, CAM climbed from #4 to #1 and STIIIZY advanced from #2 to #2 on a 39.7% YoY sales gain, indicating leaders widened separation as Greenline’s rise came mainly from the lower tiers rather than top-tier displacement. The mix of a 34-rank YoY climb and only a 1-position quarter-over-quarter drift suggests Greenline has transitioned from recovery to consolidation, implying the current trajectory points to incremental share capture that requires a step-change to breach the top 40.
Notable Products
Blood Orange Kush Badder (1g) posted the steepest decline at -43.2% month over month and slid to rank 8, while Orange Tree (3.5g) advanced +20.9% to rank 2, contrasting a retreat in one concentrate with acceleration in flagship flower. Orange Tree Pre-Roll (1g) held rank 1 with +7.5% MoM, and three Pre-Roll SKUs sit within the top ten, indicating a concentrated pull toward ready-to-consume formats over extract-led options. The Vapor Pens entry Grand Daddy Purple Distillate Sauce Cartridge (1g) dipped -1.4% at rank 5, and Concentrates occupy four of the top ten but feature mixed momentum, with Banana Gas Badder (1g) up +14.9% at rank 3 alongside the Blood Orange Kush Badder (1g) contraction. The pattern implies Greenline’s near-term commercial direction is shifting toward accessible inhalables led by Flower and Pre-Roll, with selective rationalization likely in underperforming concentrates.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
